Berlin, Germany

Horst Oloff

This inventor holds 1 USPTO granted patent. Top assignee: Schering Aktiengesellschaft. Active years: 1991.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 104(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Horst Oloff: Innovator in Transdermal Drug Delivery

Introduction

Horst Oloff is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medicinal technology, particularly in the area of transdermal drug delivery systems. His innovative approach has led to the development of a unique device that enhances the administration of active medicinal agents.

Latest Patents

Horst Oloff holds a patent for a "Device for transdermal administration of active medicinal agents." This device is characterized by its formulation, which involves the active medicinal agent being dissolved to an extent of at least 50% in a nonflowable, physiologically acceptable gel. This gel is then distributed in a microdisperse mode within a crosslinked silicone elastomer. This innovative design aims to improve the efficacy and comfort of transdermal drug delivery.

Career Highlights

Oloff has been associated with Schering Aktiengesellschaft, a prominent pharmaceutical company known for its research and development in medicinal products. His work at Schering has allowed him to focus on advancing drug delivery technologies, contributing to the company's reputation for innovation in the healthcare sector.

Collaborations

Throughout his career, Horst Oloff has collaborated with esteemed colleagues, including Fred Windt and Johannes-Wilhelm Tack. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the development of innovative solutions in the field.

Conclusion

Horst Oloff's contributions to transdermal drug delivery systems exemplify the impact of innovation in medicine. His patent and work at Schering Aktiengesellschaft highlight the importance of advancing healthcare technologies for better patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…